InnerScope Hearing Technologies : Financial and Disclosure Statements Ending 06.30.22

INNERSCOPE HEARING TECHNOLOGIES, INC.

A Nevada Corporation

2151 Professional Drive 2nd Floor,

Roseville, CA., 95661

833-788-0506www.innd.com [e-mail]

SIC Code: 5999

Quarterly Report

For the Period Ending:

06/30/2022

(the "Reporting Period")

As of June 30, 2022, the number of shares outstanding of our Common Stock was: 7,323,973,266

As of March 31, 2022, the number of shares outstanding of our Common Stock was: 7,134,403,711

As of December 31, 2021, the number of shares outstanding of our Common Stock was: 6,660,204,051

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 1 of 14

Indicate by check mark whether the Company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes: ☐

No: ☒

Indicate by check mark whether the Company's shell status has changed since the previous reporting period:

Yes: ☐

No: ☒

Indicate by check mark whether a Change in Control1 of the Company has occurred over this reporting period:

Yes: ☐

No: ☒

1. Name and address(es) of the issuer and its predecessors (if any)

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

InnerScope Hearing Technologies, Inc

InnerScope Advertising Agency, Inc. until August 2017

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

Nevada, current

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

None

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

None

1 "Change in Control" shall mean any events resulting in:

1. Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
2. The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
3. A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
4. The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 2 of 14

The address(es) of the issuer's principal executive office:

2151 Professional Drive, Second Floor, Roseville, CA 95661

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address: ☒

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes: ☐

No: ☒

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

2)	Security Information
Trading symbol:	INND
Exact title and class of securities outstanding:	Common Stock
CUSIP:		45781P104
Par or stated value:	$0.0001
Total shares authorized:	14,975,000,000as of date: August 10, 2022
Total shares outstanding:	7,407,342,166as of date: August 10, 2022
Number of shares in the Public Float2:	6,331,741,121as of date: August 10, 2022
Total number of shareholders of record:	77	as of date: August 10, 2022

All additional class(es) of publicly traded securities (if any):

Trading symbol:	N/A
Exact title and class of securities outstanding:	N/A
CUSIP:		N/A
Par or stated value:	N/A
Total shares authorized:	N/A	as of date:
Total shares outstanding:	N/A	as of date:
Transfer Agent
Name:	VStock Transfer Company
Phone:	212-828-8436
Email:	[e-mail]
Address:	18 Lafayette Place, Woodmere, NY 11598

2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.

OTC Markets Group Inc.

OTC Pink Basic Disclosure Guidelines (v3 February 2021)

Page 3 of 14

Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒

No: ☐

1. Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

1. Changes to the Number of Outstanding Shares

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐

Shares Outstanding as of Second Most

Recent Fiscal Year End:

*Right-

click the

rows

below and

Opening Balance

select

"Insert" to

add rows

as

Date 12/31/19

needed.

Common: 342,118,136

Preferred: 900,000

Were

the

share

s

issue

Reason for

Transactio

Value of

d at a

share

n type (e.g.

disco

Individual/ Entity

issuance (e.g.

new

Number of

shares

unt to

Shares were issued to

for cash or

Restricted or

Exemption

Date of

issuance,

Shares

Class of

issued

mark

(entities must have

debt

Unrestricted

or

Transaction

cancellatio

Issued (or

Securities

($/per

et

individual with voting /

conversion)

as of this

Registratio

n, shares

cancelled)

share) at

price

investment control

-OR-

filing.

n Type.

returned to

Issuance

at the

disclosed).

Nature of

treasury)

time

Services

of

Provided

issua

nce?

(Yes/

No)

Odyssey Capital

1/2/2020

Issuance

14,823,683

Common

9,339

Yes

Funding LLC

Conversion

Unrestricted

Rule 144

GS Capital Partners,

1/8/2020

Issuance

16,961,952

Common

10,686

Yes

LLC

Conversion

Unrestricted

Rule 144

1/9/2020

Issuance

17,696,079

Common

11,149

Yes

Eagle Equities, LLC

Conversion

Unrestricted

Rule 144

Odyssey Capital

1/10/2020

Issuance

17,371,683

Common

10,944

Yes

Funding LLC

Conversion

Unrestricted

Rule 144

1/16/2020

Issuance

20,387,179

Common

11,417

Yes

Eagle Equities, LLC

Conversion

Unrestricted

Rule 144

3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3 February 2021)	Page 4 of 14

						GS Capital Partners,
1/21/2020	Issuance	21,301,476	Common	8,947	Yes	LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
1/23/2020	Issuance	15,997,204	Common	7,839	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
1/24/2020	Issuance	22,465,245	Common	11,008	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
1/27/2020	Issuance	23,498,714	Common	9,869	Yes	LLC	Conversion	Unrestricted	Rule 144
1/27/2020	Issuance	19,030,000	Common	9,325	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
1/28/2020	Issuance	23,503,500	Common	9,871	Yes	LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
1/29/2020	Issuance	23,492,082	Common	11,511	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
1/30/2020	Issuance	23,546,490	Common	11,511	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
1/30/2020	Issuance	28,752,452	Common	12,076	Yes	LLC	Conversion	Unrestricted	Rule 144
2/4/2020	Issuance	23,922,694	Common	9,501	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
2/7/2020	Issuance	32,328,048	Common	9,501	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
2/10/2020	Issuance	20,981,914	Common	7,344	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
2/10/2020	Issuance	34,119,371	Common	11,942	Yes	LLC	Conversion	Unrestricted	Rule 144
2/11/2020	Issuance	25,111,371	Common	9,501	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
2/13/2020	Issuance	28,509,036	Common	9,501	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
2/18/2020	Issuance	39,031,524	Common	8,197	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
2/19/2020	Issuance	41,373,000	Common	9,501	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
2/20/2020	Issuance	43,553,333	Common	9,146	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
2/20/2020	Issuance	45,243,190	Common	9,501	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
2/20/2020	Issuance	41,572,619	Common	8,900	Yes	LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
2/24/2020	Issuance	44,127,333	Common	9,117	Yes	LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
2/25/2020	Issuance	50,113,524	Common	10,524	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
2/25/2020	Issuance	35,069,476	Common	7,365	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
3/2/2020	Issuance	55,193,714	Common	11,591	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
3/4/2020	Issuance	48,951,286	Common	6,853	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
3/9/2020	Issuance	61,739,142	Common	8,493	Yes	LLC	Conversion	Unrestricted	Rule 144
3/11/2020	Issuance	63,971,143	Common	8,956	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
3/16/2020	Issuance	67,935,000	Common	4,755	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
3/18/2020	Issuance	67,953,857	Common	4,607	Yes	LLC	Conversion	Unrestricted	Rule 144
3/19/2020	Issuance	70,725,429	Common	4,951	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
						Odyssey Capital
3/23/2020	Issuance	77,104,857	Common	5,397	Yes	Funding LLC	Conversion	Unrestricted	Rule 144
						GS Capital Partners,
3/25/2020	Issuance	82,003,142	Common	5,590	Yes	LLC	Conversion	Unrestricted	Rule 144
3/25/2020	Issuance	79,969,571	Common	5,598	Yes	Eagle Equities, LLC	Conversion	Unrestricted	Rule 144
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v3 February 2021)		Page 5 of 14